POWERFUL REDUCTION OF BODY WEIGHT

Compared to diet and exercise alone, Tirzepatide helps people lose weight six times more effectively

Overall Percent in body weight from baseline at 72 weeks

Study Design:In a 72-week medical study of 2539 adults living with obesity or overweight with a related medical problem along with a reduced-calorie diet and increased physical activity.

In addition to a reduced-calorie diet and increased physical activity, people in this study taking Tirzepatide lost more weight vs placebo.

91% of adults taking Tirzepatide 15 mg achieved clinically meaningful weight loss of ≥5% at 72 weeks compared to placebo

89% of adults taking Tirzepatide 10 mg achieved clinically meaningful weight loss of ≥5% at 72 weeks compared to placebo

85% of adults taking Tirzepatide 5 mg achieved clinically meaningful weight loss of ≥5% at 72 weeks compared to placebo

MAINTENANCE TREATMENT WITH TIRZIX(TIRZEPATIDE)

People who kept taking Tirzepatide continued to lose weight in a separate 88-week medical study

Everyone started taking Tirzepatide and was instructed to reduce calories and increase physical activity throughout the length of the study. After 32 weeks, some people continued to take Tirzepatide, while others switched to placebo. From weeks 32 to 88, people taking Tirzepatide continued to lose weight. People taking a placebo gained weight.

People taking Tirzepatide achieved lasting weight loss in a 88 week medical study